Y. Guo

发表

Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts

T. Klassen, A. Midha, M. Cox, 2015, Prostate Cancer and Prostatic Disease.

Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma.

J. Trojan., H. Duc, L. Upegui-Gonzalez, 1998, Advances in experimental medicine and biology.

Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.

N. Kyprianou, Yanping Guo, Y. Guo, 1999, Cancer research.

Altered angiogenesis underlying age-dependent changes in tumor growth.

A. Passaniti, H. Nakanishi, G. Martin, 1994, Journal of the National Cancer Institute.

Inhibition of KPNA4 attenuates prostate cancer metastasis

J. Yang, J. Wei, X. Li, 2017, Oncogene.

C. Logothetis, W. Figg, E. Reed, 2022 .

Transient suppression of X-ray-induced apoptosis by exposure to power frequency magnetic fields in MCF-7 cells.

F. Tian, J. Miyakoshi, Y. Guo, 2001, Biochemical and biophysical research communications.

Synergism between arsenic trioxide and cyclopamine in the inhibition of PC3 cell survival via the Hedgehog signaling pathway.

Y. Xu, Y. Xiong, Y. Guo, 2015, Neoplasma.

Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.

J. Cen, Y. Guo, Wenjing Yan, 2015, European review for medical and pharmacological sciences.

Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.

A. Sarasin, J. Trojan., D. Anthony, 1997, Cancer gene therapy.

Chemoprevention: progress and opportunity.

S. Clinton, Y. Guo, E. C. Miller, 2001, Advances in experimental medicine and biology.

Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.

N. Kyprianou, S. Jacobs, Y. Guo, 1997, International journal of cancer.

Altered expression of CD44 in human prostate cancer during progression.

T. P. Pretlow, S. Amini, T. Pretlow, 1996, American journal of clinical pathology.

The androgen receptor: genetic considerations in the development and treatment of prostate cancer

W. Figg, Y. Guo, S. Dixon, 1999, Journal of Molecular Medicine.

CSE1L promotes proliferation and migration in oral cancer through positively regulating MITF.

Y-S Wang, C. Peng, Y. Guo, 2020, European review for medical and pharmacological sciences.

Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.

N. Kyprianou, P. Callery, J. Eiseman, 1998, Cancer research.

A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

A. Passaniti, G. Martin, R. Pili, 1992, Laboratory investigation; a journal of technical methods and pathology.

Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway

Y. Guo, Chun Lu, Y. Guo, 2014, Oncogene.

Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling

J. Wang, X. Yang, C. Lan, 2015, Oncogene.

Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling

J. Wang, X. Yang, C. Lan, 2015, Oncogene.

Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis.

Y. Lazebnik, S. Srinivasula, E. Alnemri, 1999, Cancer research.

Loss of the Cyclin-dependent Kinase Inhibitor 27Kq Protein in Human Prostate Cancer Correlates with Tumor Grade’

Yanping, Kyprianou, A. Borkowski, 2005 .

Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.

J. J. Yu, C. Zhu, L. Chen, 2018, Neoplasma.

Benzydamine, a CDK2 Kinase Inhibitor, Suppresses The Growth of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.

X. Chen, X. He, Y. Guo, 2021 .

Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.

G. Blackburn, S. Clinton, Jin-Rong Zhou, 1999, The Journal of nutrition.

The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMEL

Y. Guo, MC Schoell, R. Freeman, 2009, Oncogene.

miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance

Zuoren Yu, Z. Ji, H. Zhu, 2017, Oncogene.

Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.

Wei Liu, Guihua Chen, Tong Zhang, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.

N. Kyprianou, Yanping Guo, Y. Guo, 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

PM2.5 exposure induces alveolar epithelial cell apoptosis and causes emphysema through p53/Siva-1

Y. Guo, Y. Guo, Q. Bai, 2020 .

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells

S. Terry, M. Benson, Yinglu Guo, 2006, Oncogene.

Mice deficient in MIM expression are predisposed to lymphomagenesis

C. Civin, M. S. Williams, S. Cherukuri, 2012, Oncogene.

The HIF/PHF8/AR axis promotes prostate cancer progression

Y. Wang, W. Yuan, S. Dong, 2016, Oncogenesis.

Overexpression of platelet-derived growth factor-B increases the growth, invasion, and angiogenesis of gastric carcinoma cells through protein kinase B.

Y. Guo, L. Zha, Y. Guo, 2013, Neoplasma.

Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy.

E. Bruckheimer, N. Kyprianou, Yanping Guo, 2000, Histology and histopathology.

The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib-resistant K562R leukemia cells.

Y. Guo, J. Lin, Y. Gong, 2014, Die Pharmazie.